CN105561398A - 一种组织工程多孔细胞外基质支架制备方法 - Google Patents
一种组织工程多孔细胞外基质支架制备方法 Download PDFInfo
- Publication number
- CN105561398A CN105561398A CN201510664734.4A CN201510664734A CN105561398A CN 105561398 A CN105561398 A CN 105561398A CN 201510664734 A CN201510664734 A CN 201510664734A CN 105561398 A CN105561398 A CN 105561398A
- Authority
- CN
- China
- Prior art keywords
- support
- scaffold
- tissue
- extracellular matrix
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000001519 tissue Anatomy 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 title claims abstract description 13
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 title claims abstract description 13
- 210000002744 extracellular matrix Anatomy 0.000 title claims abstract description 13
- 229920000642 polymer Polymers 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 8
- 230000007246 mechanism Effects 0.000 claims abstract description 4
- 238000001727 in vivo Methods 0.000 claims abstract description 3
- 210000004027 cell Anatomy 0.000 claims description 21
- 229920001610 polycaprolactone Polymers 0.000 claims description 19
- 239000004632 polycaprolactone Substances 0.000 claims description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000007943 implant Substances 0.000 claims description 15
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 13
- 230000002632 myometrial effect Effects 0.000 claims description 10
- 241001465754 Metazoa Species 0.000 claims description 9
- 238000007920 subcutaneous administration Methods 0.000 claims description 7
- 241000282472 Canis lupus familiaris Species 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 6
- 241001494479 Pecora Species 0.000 claims description 6
- 241000700159 Rattus Species 0.000 claims description 6
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 6
- 238000010041 electrostatic spinning Methods 0.000 claims description 6
- 238000002074 melt spinning Methods 0.000 claims description 5
- 230000017423 tissue regeneration Effects 0.000 claims description 5
- 238000010171 animal model Methods 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 210000004204 blood vessel Anatomy 0.000 claims description 3
- 210000000845 cartilage Anatomy 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 238000002166 wet spinning Methods 0.000 claims description 3
- 238000010146 3D printing Methods 0.000 claims description 2
- 241000699670 Mus sp. Species 0.000 claims description 2
- 210000000683 abdominal cavity Anatomy 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 230000001537 neural effect Effects 0.000 claims description 2
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 claims description 2
- 229920002627 poly(phosphazenes) Polymers 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 41
- 238000002513 implantation Methods 0.000 abstract description 22
- 210000000056 organ Anatomy 0.000 abstract description 10
- 239000011148 porous material Substances 0.000 abstract description 8
- 230000001900 immune effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000005847 immunogenicity Effects 0.000 abstract description 2
- 210000001015 abdomen Anatomy 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 description 29
- 230000001413 cellular effect Effects 0.000 description 25
- 230000001954 sterilising effect Effects 0.000 description 21
- 239000000835 fiber Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 10
- 238000009987 spinning Methods 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 238000001291 vacuum drying Methods 0.000 description 9
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 8
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 8
- 238000004043 dyeing Methods 0.000 description 8
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 238000010166 immunofluorescence Methods 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 7
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 6
- 230000035617 depilation Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 229960004756 ethanol Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002062 molecular scaffold Substances 0.000 description 4
- 230000003387 muscular Effects 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000004626 polylactic acid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000002121 nanofiber Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510664734.4A CN105561398B (zh) | 2015-10-13 | 2015-10-13 | 一种组织工程多孔细胞外基质支架制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510664734.4A CN105561398B (zh) | 2015-10-13 | 2015-10-13 | 一种组织工程多孔细胞外基质支架制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105561398A true CN105561398A (zh) | 2016-05-11 |
CN105561398B CN105561398B (zh) | 2022-03-22 |
Family
ID=55872387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510664734.4A Active CN105561398B (zh) | 2015-10-13 | 2015-10-13 | 一种组织工程多孔细胞外基质支架制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105561398B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105999414A (zh) * | 2016-06-20 | 2016-10-12 | 清华大学 | 制备人造微环境的方法及其应用 |
CN107648669A (zh) * | 2017-10-24 | 2018-02-02 | 武汉大学 | 构建血管化组织工程骨膜的方法 |
WO2018023840A1 (zh) * | 2016-08-05 | 2018-02-08 | 华中科技大学同济医学院附属协和医院 | 一种人造血管及其制备方法 |
CN107715183A (zh) * | 2017-09-08 | 2018-02-23 | 浙江大学 | 一种具有螺旋取向结构的壳聚糖接骨钉材料及其制备方法 |
CN109199649A (zh) * | 2018-08-30 | 2019-01-15 | 中国人民解放军总医院 | 组织工程半月板复合支架及其制备方法 |
CN110201223A (zh) * | 2019-03-26 | 2019-09-06 | 南开大学 | 一种合成高分子与天然细胞外基质复合材料、人工血管及其制备方法 |
CN110641012A (zh) * | 2019-09-25 | 2020-01-03 | 青岛五维智造科技有限公司 | 聚合物全降解血管支架微尺度3d打印制备方法、装置及其应用 |
CN110944654A (zh) * | 2017-07-14 | 2020-03-31 | 武汉市康创科技有限公司 | 一种包含脱细胞羊膜的复合膜及其制备方法 |
CN113144295A (zh) * | 2021-04-29 | 2021-07-23 | 武汉理工大学 | 基于细胞外基质材料制备的双层人工真皮及其制备方法 |
CN113244460A (zh) * | 2021-04-29 | 2021-08-13 | 南开大学 | 一种促进组织再生的取向微通道支架及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005009497A1 (en) * | 2003-07-17 | 2005-02-03 | Boston Scientific Limited | Decellularized extracellular matrix of conditioned body tissues and uses thereof |
CN1800372A (zh) * | 2005-12-02 | 2006-07-12 | 王平安 | 组织工程化细胞外基质的制备方法 |
CN101579539A (zh) * | 2009-06-18 | 2009-11-18 | 重庆文理学院 | 一种粘结型复合微球多孔支架的制备方法 |
-
2015
- 2015-10-13 CN CN201510664734.4A patent/CN105561398B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005009497A1 (en) * | 2003-07-17 | 2005-02-03 | Boston Scientific Limited | Decellularized extracellular matrix of conditioned body tissues and uses thereof |
CN1800372A (zh) * | 2005-12-02 | 2006-07-12 | 王平安 | 组织工程化细胞外基质的制备方法 |
CN101579539A (zh) * | 2009-06-18 | 2009-11-18 | 重庆文理学院 | 一种粘结型复合微球多孔支架的制备方法 |
Non-Patent Citations (1)
Title |
---|
吴延平等: "聚羟基烷酸酯聚合物负载软骨细胞修复同种异体喉软骨缺损", 《中国组织工程研究》 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105999414B (zh) * | 2016-06-20 | 2019-12-17 | 清华大学 | 制备人造微环境的方法及其应用 |
CN105999414A (zh) * | 2016-06-20 | 2016-10-12 | 清华大学 | 制备人造微环境的方法及其应用 |
WO2018023840A1 (zh) * | 2016-08-05 | 2018-02-08 | 华中科技大学同济医学院附属协和医院 | 一种人造血管及其制备方法 |
CN110944654B (zh) * | 2017-07-14 | 2023-09-12 | 武汉市康创科技有限公司 | 一种包含脱细胞羊膜的复合膜及其制备方法 |
CN110944654A (zh) * | 2017-07-14 | 2020-03-31 | 武汉市康创科技有限公司 | 一种包含脱细胞羊膜的复合膜及其制备方法 |
CN107715183A (zh) * | 2017-09-08 | 2018-02-23 | 浙江大学 | 一种具有螺旋取向结构的壳聚糖接骨钉材料及其制备方法 |
CN107648669A (zh) * | 2017-10-24 | 2018-02-02 | 武汉大学 | 构建血管化组织工程骨膜的方法 |
CN109199649B (zh) * | 2018-08-30 | 2019-12-03 | 中国人民解放军总医院 | 组织工程半月板复合支架及其制备方法 |
WO2020042674A1 (zh) * | 2018-08-30 | 2020-03-05 | 中国人民解放军总医院 | 组织工程半月板复合支架及其制备方法 |
CN109199649A (zh) * | 2018-08-30 | 2019-01-15 | 中国人民解放军总医院 | 组织工程半月板复合支架及其制备方法 |
CN110201223A (zh) * | 2019-03-26 | 2019-09-06 | 南开大学 | 一种合成高分子与天然细胞外基质复合材料、人工血管及其制备方法 |
CN110641012A (zh) * | 2019-09-25 | 2020-01-03 | 青岛五维智造科技有限公司 | 聚合物全降解血管支架微尺度3d打印制备方法、装置及其应用 |
CN113144295A (zh) * | 2021-04-29 | 2021-07-23 | 武汉理工大学 | 基于细胞外基质材料制备的双层人工真皮及其制备方法 |
CN113244460A (zh) * | 2021-04-29 | 2021-08-13 | 南开大学 | 一种促进组织再生的取向微通道支架及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105561398B (zh) | 2022-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105561398A (zh) | 一种组织工程多孔细胞外基质支架制备方法 | |
US20230061170A1 (en) | Fiber scaffolds for use creating implantable structures | |
Hodde | Naturally occurring scaffolds for soft tissue repair and regeneration | |
Mohamed et al. | Nanomaterials and nanotechnology for skin tissue engineering | |
Hadlock et al. | A polymer foam conduit seeded with Schwann cells promotes guided peripheral nerve regeneration | |
Yang et al. | Emerging 3D bioprinting applications in plastic surgery | |
CN105999419B (zh) | 一种仿生型可吸收硬脑膜补片及其制备方法与应用 | |
CN101829361B (zh) | 一种用于组织修复的纳米仿生材料及其制备方法 | |
CN103800097B (zh) | 一种组织修复用纤维膜及其制造方法和应用 | |
CN105705172B (zh) | 用于组织再生的亲水性静电纺生物复合支架材料及其制法与应用 | |
CN111714706B (zh) | 可促进血管细胞增殖和分泌细胞外基质的血管支架、血管支架的制备方法及活性人工血管 | |
JP6196217B2 (ja) | 筋線維断片を利用した筋組織再生 | |
CN104474589A (zh) | 一种引导组织再生膜及其制备方法与应用 | |
CN105536055B (zh) | 一种形状记忆型高弹性活性纳米纤维支架及其应用 | |
CN114225111A (zh) | 一种具有可控孔道结构细胞外基质支架材料制备方法 | |
CN105339018A (zh) | 组织修复支架及其制备方法和用途 | |
CN103127548B (zh) | 促进神经缺损修复的人工神经导管的制备方法 | |
CN113786516B (zh) | 一种PCL/Col/MC梯度三层人工骨膜及其制备方法与应用 | |
Arab et al. | Novel ultrashort self-assembling peptide bioinks for 3D culture of muscle myoblast cells | |
CN106902389A (zh) | 一种纳米纤维表面改性的异种脱细胞神经移植物及其制备方法 | |
CN108409938A (zh) | 一种新型可降解聚氨酯生物材料及其制备方法和应用 | |
KR20220156886A (ko) | 흡수성 재료로 만든 스캐폴드를 이용한 생체 내 조직 엔지니어링 장치, 방법, 그리고 재생 및 세포 의학 | |
CN109381732A (zh) | 负载生长因子小分子抑制剂的静电纺丝敷料、其制备方法及应用 | |
CN106334210A (zh) | 一种多功能胶原蛋白纳米纤维修复膜及其制备方法 | |
Xia et al. | Emerging polymeric biomaterials and manufacturing techniques in regenerative medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20160511 Assignee: Lingbo Biotechnology (Hangzhou) Co.,Ltd. Assignor: NANKAI University Contract record no.: X2023990000604 Denomination of invention: A method for preparing porous extracellular matrix scaffolds for tissue engineering Granted publication date: 20220322 License type: Common License Record date: 20230613 |
|
EM01 | Change of recordation of patent licensing contract | ||
EM01 | Change of recordation of patent licensing contract |
Change date: 20240419 Contract record no.: X2023990000604 License type after: Exclusive license License type before: General permission |